We are live on ! Find out more
QNCX icon

Quince Therapeutics
QNCX

63 hedge funds and large institutions have $523M invested in Quince Therapeutics in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

650% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 13

26% more funds holding

Funds holding: 50 → 63 (+13)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% less ownership

Funds ownership: 0.2% → 0.19% (-0%)

12% less capital invested

Capital invested by funds: $594M → $523M (-$71.6M)

Holders
63
Holders Change
+13
Holders Change %
+26%
% of All Funds
1.39%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
26
Reduced
13
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$12.2M
2
Capital World Investors
Capital World Investors
California
+$8.44M
3
PHAM
Pacific Heights Asset Management
California
+$5.68M
4
Capital Research Global Investors
Capital Research Global Investors
California
+$4.87M
5
BlackRock
BlackRock
New York
+$3.32M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$3.86M
2
MWNA
Marshall Wace North America
New York
-$3.26M
3
Invesco
Invesco
Georgia
-$1.26M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$681K
5
Goldman Sachs
Goldman Sachs
New York
-$443K
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
51
BNP Paribas Financial Markets
France
$158K +$88.8K +9 +113%
Citigroup
52
Citigroup
New York
$158K +$49.4K +5 +42%
Marshall Wace
53
Marshall Wace
United Kingdom
$150K +$158K +16 New
Victory Capital Management
54
Victory Capital Management
Texas
$148K +$158K +16 New
AI
55
ArchPoint Investors
Florida
$140K +$69.1K +7 +88%
ACA
56
Atlas Capital Advisors
Wyoming
$137K – – –
Legal & General Group
57
Legal & General Group
United Kingdom
$84K -$29.6K -3 -25%
GSWM
58
Golden State Wealth Management
California
$46K +$49.4K +5 New
AIP
59
Ameritas Investment Partners
Nebraska
$45K – – –
PA
60
Parallel Advisors
California
$43K +$49.4K +5 New
SO
61
STRS Ohio
Ohio
$36K – – –
TRCT
62
Tower Research Capital (TRC)
New York
$15K +$19.7K +2 New
Bank of Montreal
63
Bank of Montreal
Ontario, Canada
$4K -$69.1K -7 -88%
ASN
64
Advisory Services Network
Georgia
$2K – – –
Royal Bank of Canada
65
Royal Bank of Canada
Ontario, Canada
$2K – – –
Osaic Holdings
66
Osaic Holdings
Arizona
$1K – – –
Goldman Sachs
67
Goldman Sachs
New York
– -$443K -39 Closed
OAM
68
Oxford Asset Management
United Kingdom
– -$398K -35 Closed
1 2
3

QNCX Hedge Fund Activity: Q1 2020 in Review

63 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Quince Therapeutics (QNCX) for Q1 2020, worth a combined $523M — down 12% from $594M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new QNCX positions and 2 closed out — a net gain of 13 holders — while 26 added to existing stakes and 13 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $12.2M. The largest seller was Morgan Stanley, cutting an estimated $3.86M.

  • 63 institutional investors held Quince Therapeutics (QNCX) as of Q1 2020, up from 50 in Q4 2019.
  • Funds reported $523M of Quince Therapeutics stock for Q1 2020, down 12% quarter-over-quarter.
  • 15 funds opened new Quince Therapeutics positions in Q1 2020 and 2 closed out, a net change of +13 holders.
  • The largest Quince Therapeutics buyer in Q1 2020 was Citadel Advisors, an estimated $12.2M added.
  • The largest Quince Therapeutics seller in Q1 2020 was Morgan Stanley, an estimated $3.86M sold.

Based on aggregated 13F filings for Q1 2020.